Gara Jalqabaatti › Kansa Mataa fi Morma › Illinois › Chicago
Qorannoo klinikaalii Kansa Mataa fi Morma Chicago, IL keessatti
Qorannoo 10 Kansa Mataa fi Morma f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
Namoota walitti qabaa jiraSadarkaa 2/3
- Captain James A Lovell Federal Health Care Center-VA North Chicago (Site # 133), Chicago
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- University of Illinois Cancer Center, Chicago
A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
Namoota walitti qabaa jiraSadarkaa 2
- The University of Chicago, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Chicago, Chicago
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Chicago Comprehensive Cancer Center, Chicago
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Namoota walitti qabaa jiraSadarkaa 1
- The University of Chicago, Chicago
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
Namoota walitti qabaa jiraSadarkaa 2
- The University of Chicago, Chicago
Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC
Namoota walitti qabaa jiraSadarkaa 1
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chicago
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Illinois at Chicago, Chicago
Qorannoo Kansa Mataa fi Morma magaalota biroo keessatti
- Houston, TXQorannoo 30
- Boston, MAQorannoo 22
- New York City, NYQorannoo 21
- Nashville, TNQorannoo 21
- St. Louis, MOQorannoo 15
- Dallas, TXQorannoo 12
- Pittsburgh, PAQorannoo 11
- Los Angeles, CAQorannoo 10
- San Antonio, TXQorannoo 10
- Baltimore, MDQorannoo 10
- Washington, DCQorannoo 10
- Durham, NCQorannoo 10
Qorannoo biroo Chicago keessatti
- Kansara Qara'a Non-Small CellQorannoo 61
- Saree OljooQorannoo 59
- Saree (Gosoota Hunda)Qorannoo 51
- Kansara MetastatikiiQorannoo 45
- Kansarii ProstateQorannoo 45
- Dhibee QaraQorannoo 41
- ObesityQorannoo 41
- Kansarii OvariiQorannoo 36
- Kansarii ColorectalQorannoo 34
- StrokeQorannoo 34
- Cufama OnneeQorannoo 31
- Baayyee UlfaataaQorannoo 29
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.